Document is current
Any future updates will be listed below
-
Authors
Sarcinelli, G. M.
Varinelli, L.
Ghislanzoni, S.
Padelli, F.
Lorenzini, D.
Vingiani, A.
Milione, M.
Guaglio, M.
Kusamura, S.
Deraco, M.
Pruneri, G.
Gariboldi, M.
Baratti, D.
Bongarzone, I.
-
Funding
Funding for this research was provided by:
Italian Ministry of Public Health (RF 2019-12370456)
Italian Ministry of Public Health (RF 2019-12370456)
Italian Ministry of Public Health (RF 2019-12370456)
Italian Ministry of Public Health (RF 2019-12370456)
Italian Ministry of Public Health (RF 2019-12370456)
Italian Ministry of Public Health (RF 2019-12370456)
Italian Ministry of Public Health (RF 2019-12370456)
Institutional grant (BRI 2021)
Institutional grant (BRI 2021)
Institutional grant (BRI 2021)
Institutional grant (BRI 2021)
Institutional grant (BRI 2021)
Institutional grant (BRI 2021)
European Union’s Horizon 2020 research and innovation programme (grant agreement No 101016923 (101.13039/100010661))
European Union’s Horizon 2020 research and innovation programme (grant agreement No 101016923 (101.13039/100010661))
European Union’s Horizon 2020 research and innovation programme (grant agreement No 101016923 (101.13039/100010661))
- License Information
-
More Information
Article History
Received: 8 January 2024
Accepted: 19 June 2024
First Online: 28 June 2024
Declarations
:
: The study was conducted according to the Declaration of Helsinki and approved by the local Ethics Committee (Fondazione Istituto Nazionale dei Tumori, Milano prot. n. (134/13; I249/19). Written informed consent was obtained by all cancer patients enrolled in the study.
: The authors declare no competing interests.
